Menu
ncarol.com
  • Home
  • Financial
  • Business
  • Education
  • Health
  • Stocks
  • Banking
  • Finance
  • Nyse
ncarol.com

Certified Nutraceuticals Partners with Colorado Researchers for Groundbreaking Study on KollaJell™ and Brain Health
ncarol.com/10282619

Trending...
  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
  • UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
  • NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
Certified Nutraceuticals, Inc.
The study aims to validate KollaJell™ as the first and only collagen-based brain health product backed by clinical trials.

TEMECULA, Calif. - ncarol.com -- Temecula, CA—Certified Nutraceuticals Inc. announced the start of a clinical study on the cognitive benefits of KollaJell™, a patented jellyfish collagen supplement uniquely formulated to support brain health. The study aims to validate KollaJell™ as the first and only collagen-based brain health product backed by clinical trials.

The innovative study will utilize advanced brain imaging technologies, including electroencephalographic (EEG) scans, to measure cognitive function and brain activity before and after KollaJell™ supplementation. The project also utilizes computerized cognitive assessments to evaluate critical mental performance domains such as memory and multitasking. Results of this unique investigation are anticipated by April 2025 and will be published in peer-reviewed scientific journals.

The research team consists of Dr. G.M. Haase, who has developed numerous innovations in nutritional science, holds 12 U.S. patents, and has published 200 research papers. Neil Wolkodoff, Ph.D., is the Medical Program Director of the Colorado Center for Health and Sport Science and is an expert in health and performance metrics.

More on ncarol.com
  • Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
  • Deborah E. Jones Introduces Emotional Sovereignty, a Powerful New Book on Emotional Mastery, Resilience, and Intentional Living
  • New Research Identifies "The Busy Effect": 89% of Americans Want a Laid-Back Vacation — Only 15% Actually Achieve It
  • Alchemy 43 Appoints Shane Smith as CEO to Drive Operational Performance and Scalable Growth
  • New from Regal House Publishing, Pinkie's Turnabout, a girl fights to adopt a cat to save her

Abdul Alkayali, Senior Vice President of Certified Nutraceuticals noted, "CN has been at the forefront of nutritional innovation, with KollaJell™ standing as a testament to our commitment to science-backed health solutions. This clinical study represents a significant step toward establishing KollaJell™ as the only brain health supplement with academic-led clinical validation. The study will solidify the product's credibility and enhance our global market presence."

About Certified Nutraceuticals

Certified Nutraceuticals develops natural, functional, ingredient-based compounds that promote healthy and active lifestyles. Products are rooted in traditional medicine and validated by modern science and impact anti-aging on a cellular level, joint, brain, cardiovascular, and immune health.

Learn more at www.certifiednutra.com

Media Contact: Sara Alkayali, 951-600-3899.  Email: salkayali@certifiednutra.com

Media Contact
Abdul Alkayali
asalkayali@certifiednutra.com
951-600-3899


Source: Certified Nutraceuticals
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Quality Water Treatment Unveils SoftPro Elite HE Water Softener for City Water, Setting a New Standard in Residential Water Treatment
  • UK Financial Ltd Chooses PUMP.FUN App to Launch Maya Meme's Minor-League Meme Coins and Announces Lifetime Airdrop Program
  • Boston Industrial Solutions Expands Its Industry-Leading UV Ink Portfolio with the Launch of a Matte Ink - Natron® UVPZ
  • Vision Elite Royalty Announces Major Rebrand
  • Providence Place Hosts Community Easter Event for Local Children in High Point
  • Century Fasteners Corp. Exhibiting at 2026 MRO Americas Show – April 21-23, 2026 – Booth #2257
  • Why Most "Artist Deals" Are Just Repackaged Services — And What Real Music Infrastructure Really Is
  • Blue Sparrow Coffee named Best Matcha in Westword's Best of Denver 2026
  • Ocean County College Introduces Pathways to Simplify the Student Journey and Strengthen Career Connections
  • Kiko Nation Expands to Apple App Store, Achieving Full Mobile Deployment for Livestock Digital Registry Platform
  • The Lawyers' Marketer Launches Claude AI Implementation Service for Law Firms
  • Certified Trading Card Association and Collectors MD Launch Healthy Hobby Initiative
  • Independent Artist Builds AI-Driven Soul Collective to Scale Music Creation
  • L2 Aviation Earns FAA STC for Thales AVIATOR 200S for Boeing 777
  • FinIQ Edu Launches High-Impact Workshop Vertical to Close the Workplace Benefits Gap—Drives 82% Surge in 401(k) Participation Intent
  • HousingWire launches Mortgage Rankings, bringing a data-driven benchmark to originator performance
  • J&J Exterminating Reminds Residents to prepare for Termite Swarm Season
  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
  • Charlotte-based PR Founder + Expert Launches New Website Highlighting Brand Astrology™ Methodology
  • Just 1 in 57 Crypto Owners Globally Pay Taxes on Their Holdings, New Report Finds
_catLbl0 _catLbl1

Popular on ncarol.com

  • Training Lofts Launches $1,099 Unlimited Training Membership Featuring Semi-Private Coaching, Nutrition Support, and Recovery Services - 105
  • Inkdnylon Custom Apparel Launches Cost-Saving System for Promotional Products and Custom Apparel in Chicago
  • Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets
  • Elder Abuse Case Against Healthy Traditions Owner Raises Questions As To The Dire Reality Of Abuse Against The Last Of The Baby Boomers
  • Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
  • Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
  • Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
  • Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
  • Heritage at Manalapan Introduces New Single-Family Home Community in One of Monmouth County's Most Desirable Locations
  • Dr. Sheel Desai Solomon and Preston Dermatology Continue Awards Streak with Top Honors in 2026 Maggy Awards

Similar on ncarol.com

  • Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
  • Deborah E. Jones Introduces Emotional Sovereignty, a Powerful New Book on Emotional Mastery, Resilience, and Intentional Living
  • Alchemy 43 Appoints Shane Smith as CEO to Drive Operational Performance and Scalable Growth
  • Best Spiritual Healing, Meditation & Retreats in Sedona — Rise Meditation Helps You Find and Book Transformational Experiences
  • 3rd Annual Meditative Melodies Event Brings Global Arts and Guided Wellness to Charlotte on April 18
  • AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
  • purelyIV Launches Lab Testing Services in Metro Detroit
  • NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
  • Nufabrx Added to TrillaMed Pharmacy and DAPA Contracts
  • CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute